Bruce Booth, Director, Ten Percent Owner at Larimar Therapeutics, holds 685.39K shares in Kymera Therapeutics (Ticker: KYMR), holds 3.00M shares in Sionna Therapeutics, Inc. (Ticker: SION), holds 0.00 shares in Vigil Neuroscience Inc (Ticker: VIGL). Most recently, Bruce Booth Sold ― shares of Kymera Therapeutics on Dec 12, 2025 for an estimated value of $21.70M.
Bruce Booth latest transaction was an Informative Sell of $21.70M.
What was Bruce Booth's most profitable transaction?
Bruce Booth’s most profitable transaction was an Informative Buy of SION stock on February 10, 2025. The return on the trade was 90.50%.
What is Bruce Booth's role in Larimar Therapeutics?
Bruce Booth's role in Larimar Therapeutics is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.